Physician profile
Geoffrey D Young
NPI 1013174481
$22,084.21
in general payments reported to CMS, 2019-2025
16 companies · $15K in 2025
The $15K reported for 2025 was more than what 95% of Surgical Oncology providers received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $963 · 2021: $192 · 2022: $222 · 2023: $4,873 · 2024: $815 · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $17K · Travel and Lodging: $2,072 · Food and Beverage: $1,202.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $17,433.00 |
| Travel and Lodging | $2,072.08 |
| Food and Beverage | $1,202.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $9,569.70 | 2023-2025 | Libtayo, Dupixent |
| Emd Serono, INC. | $4,725.00 | 2023 | |
| Precigen, INC. | $4,500.00 | 2025 | |
| Axogen | $1,005.86 | 2019-2024 | Axoguard Nerve Protector, Axoguard Nerve Cap, Axoguard Ha+ Nerve Protector |
| Intuitive Surgical, INC. | $583.88 | 2024 | |
| Merck Sharp & Dohme LLC | $440.86 | 2025 | Keytruda |
| Medtronic, INC. | $382.11 | 2024-2025 | Pteye Parathyroid Detection System |
| Depuy Synthes Sales INC. | $193.99 | 2024-2025 | Na |
| Acera Surgical, INC. | $148.63 | 2025 | Restrata Wound Matrix |
| E.R. Squibb & Sons, L.L.C. | $124.87 | 2022 | |
| Genzyme Corporation | $124.80 | 2021 | |
| Bolder Surgical, LLC | $96.85 | 2022 | |
| Hologic Sales and Service, LLC | $68.43 | 2023 | Coolseal Generator |
| Atos Medical INC | $50.00 | 2021 | |
| Checkpoint Surgical, INC | $39.42 | 2021-2023 | Checkpoint Stimulators |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $29.81 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Geoffrey Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.